PMID- 12185492 OWN - NLM STAT- MEDLINE DCOM- 20030212 LR - 20131121 IS - 0937-9827 (Print) IS - 0937-9827 (Linking) VI - 116 IP - 4 DP - 2002 Aug TI - Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rabbit. Part I: experimental approach after in vivo intravenous infusion. PG - 216-24 AB - Post-mortem redistribution is known to influence blood and tissue levels of various drugs. An animal model was used in an attempt to elucidate this problem for the amphetamine analogue, 3,4-methylenedioxymethamphetamine (MDMA). Rabbits received 1 mg/kg MDMA intravenously (iv) and were killed 2 h later in order to simulate the state of complete distribution in the body. MDMA and 3,4-methylenedioxyamphetamine (MDA) concentrations were determined in blood, urine, bile, vitreous humour, and various tissues (eye globe walls, brain, cardiac muscle, lungs, liver, kidneys, iliopsoas muscle and adipose tissue) using a high pressure liquid chromatographic (HPLC) procedure with fluorescence detection. In the first group (control group, sampling immediately post mortem) considerable MDMA concentrations were found in the brain and both lungs. In addition, our data indicate the elimination of MDMA by hepatic biotransformation and excretion via the bile. When the animals were preserved either 24 or 72 h post mortem (second group), an increase of MDMA and MDA levels in the liver and the eye globe walls was noticed. In the lungs, on the other hand, they tended to decline as a function of increasing post-mortem interval. MDMA levels in cardiac and iliopsoas muscle were fairly comparable and remained stable up to 72 h after death. In the third group, ligation of the large vessels around the heart took place immediately post mortem, but significant differences in blood and tissue MDMA concentrations between rabbits of group 2 and 3 could not be demonstrated. We therefore conclude that post-mortem redistribution of MDMA at the cellular level (viz. by pure diffusion gradient from higher to lower concentrations) is more important than its redistribution via the vascular pathway. Finally, MDA levels were relatively low in all samples, thus indicating that this is not a major metabolite in the rabbit, at least within the first 2 h after administration. FAU - De Letter, Els A AU - De Letter EA AD - Ghent University, Department of Forensic Medicine, J. Kluyskensstraat 29, 9000 Ghent, Belgium. FAU - Clauwaert, Karine M AU - Clauwaert KM FAU - Belpaire, Frans M AU - Belpaire FM FAU - Lambert, Willy E AU - Lambert WE FAU - Van Bocxlaer, Jan F AU - Van Bocxlaer JF FAU - Piette, Michel H A AU - Piette MH LA - eng PT - Journal Article DEP - 20020528 PL - Germany TA - Int J Legal Med JT - International journal of legal medicine JID - 9101456 RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Chromatography, High Pressure Liquid MH - Female MH - Models, Animal MH - N-Methyl-3,4-methylenedioxyamphetamine/blood/*pharmacokinetics MH - *Postmortem Changes MH - Rabbits MH - Sensitivity and Specificity MH - Spectrometry, Fluorescence MH - Tissue Distribution EDAT- 2002/08/20 10:00 MHDA- 2003/02/14 04:00 CRDT- 2002/08/20 10:00 PHST- 2001/09/10 00:00 [received] PHST- 2001/12/27 00:00 [accepted] PHST- 2002/08/20 10:00 [pubmed] PHST- 2003/02/14 04:00 [medline] PHST- 2002/08/20 10:00 [entrez] AID - 10.1007/s00414-002-0292-0 [doi] PST - ppublish SO - Int J Legal Med. 2002 Aug;116(4):216-24. doi: 10.1007/s00414-002-0292-0. Epub 2002 May 28.